Actinogen Medical Limited (ASX:ACW)
Australia · Delayed Price · Currency is AUD 0.0390
-0.0010 (-2.50%)
Mar 11, 2026, 3:58 PM AEST
Actinogen Medical Market Cap
Actinogen Medical has a market cap or net worth of 143.03 million as of March 10, 2026. Its market cap has increased by 23.39% in one year.
Market Cap
143.03M
Enterprise Value
136.72M
Revenue
7.36M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.04
Market Cap Chart
Since October 16, 2007, Actinogen Medical's market cap has increased from 12.97M to 143.03M, an increase of 1,002.54%. That is a compound annual growth rate of 13.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 10, 2026 | 143.03M | -26.43% |
| Dec 31, 2025 | 194.40M | 148.21% |
| Dec 31, 2024 | 78.32M | 54.29% |
| Dec 29, 2023 | 50.76M | -71.90% |
| Dec 30, 2022 | 180.63M | -36.39% |
| Dec 31, 2021 | 283.98M | 832.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Orthocell | 240.11M |
| Dimerix | 225.15M |
| Tetratherix | 196.97M |
| Starpharma Holdings | 170.07M |
| Recce Pharmaceuticals | 133.02M |
| Botanix Pharmaceuticals | 126.43M |
| Island Pharmaceuticals | 125.28M |
| Paradigm Biopharmaceuticals | 112.01M |